Annual Symposium on Nonhuman Primates
Annual Symposium on Nonhuman Primates
批准号:
10676977
负责人:
R. PAUL JOHNSON
金额:
$7.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-15 至 2025-07-31
关键词:
AIDS VaccinesAccelerationAcquired Immunodeficiency SyndromeAddressAdultAntibodiesApplications GrantsBudgetsCOVID-19 pandemicCOVID-19 pathogenesisCOVID-19 treatmentCOVID-19 vaccineCaliforniaChildClinicClinicalCollaborationsCommunicable DiseasesDevelopmentDiseaseEmerging TechnologiesFeesFosteringFundingFutureGenerationsGenomicsGrantHIVHIV InfectionsHIV Vaccine Trials NetworkHIV vaccineHIV/AIDSHealthHumanHybridsImmunologic Deficiency SyndromesImmunologyIndividualInternationalInterventionJournalsKnowledgeLifeLinkLogisticsMedicalMentorsMissionModelingNIH Vaccine Research CenterOralOregonParticipantPathogenesisPennsylvaniaPersonsPreventionPreventive vaccinePrimatesPublishingResearchResearch PersonnelRoleRotationSIVScientific Advances and AccomplishmentsScientistTechnologyTestingTranslationsUnited States National Institutes of HealthVaccinesVirus DiseasesWritingantiretroviral therapyco-infectioncoronavirus diseasecostdisabilityexperiencefallsglobal healthmeetingsneutralizing antibodynonhuman primatenovel therapeuticsoriginalityposterspreventprogramsresponsesymposiumtherapy designtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
With this R13 application, we request funding to support, in part, the costs for planning, publicizing, and hosting
the 39th, 40th, and 41st Annual Symposia on Nonhuman Primate Models for AIDS. For four decades, this
symposium has served as the premier scientific forum for the exchange of information, including new research
findings and scientific perspectives, among HIV/AIDS investigators whose research includes studies in
nonhuman primates (NHPs). Disseminating the latest research findings in NHP models of AIDS while also
facilitating discussion and exchange of information between basic scientists and clinicians remains a priority,
as do focusing on emerging technologies to accelerate translation of NHP studies into the clinic and engaging
a broader and more diverse group of researchers in HIV/AIDS research in NHP models. This meeting, the only
one of its kind in the world, convenes an international group of scientists whose research focuses on the study
of natural and experimental immunodeficiency virus infections in NHPs, as well as on the development of novel
therapeutics, prophylactic vaccines for HIV, and curative approaches. Emerging topics in related infectious
diseases (such as COVID-19 pathogenesis, vaccines and treatment) may also be included. The seven National
Primate Research Centers (NPRCs) host this meeting in rotation, and upcoming symposia hosts will be the
Yerkes (2022), California (2023), and Tulane (2024) NPRCs. We plan a hybrid format with most participants
attending in person and others joining online to access oral and poster sessions. The conference will begin on
day 1 with registration, a keynote address by a leading HIV/AIDS researcher, and an evening reception. The
following two and a half days will include scientific presentations from invited speakers and accepted oral
abstracts. Each symposium scientific committee will select session topics and speakers to highlight new and
cutting-edge technologies in their respective fields. Each session will open with a 30-minute talk by an invited
chair. Individuals whose abstracts are accepted for oral presentations will give the remaining session talks. A
poster session will occur on the evening of day 2, and there will be a banquet on the evening of day 3. As is
traditional for this symposium, the Journal of Medical Primatology will publish all poster and oral abstracts in a
special issue. In partnership with the HIV Vaccine Trials Network (HVTN), the NHP AIDS Symposium will also
host a pre-symposium meeting for early stage investigators (ESI). This meeting will be open to the attendees
of a linked ESI Conference the HVTN sponsors. ESI attendees and mentors will focus on grant writing,
budgeting, and networking, and will participate in a Q&A with NIH Program Officers. We believe bringing
together researchers from a variety of diverse backgrounds will generate future collaborations and scientific
advances. Knowledge shared and gained at upcoming Annual Nonhuman Primate Models for AIDS Symposia
will further the continued, effective use of NHP models to maintain long term control of HIV replication in the
absence of antiretroviral therapy and to design interventions to prevent or eradicate HIV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Annual Symposium on Nonhuman Primates
-
批准号:10554035
-
项目类别:
-
资助金额:$7.5万
-
财政年份:2022
-
负责人:R. PAUL JOHNSON
-
依托单位:
Exome screening and directed breeding of rhesus for human genetic disease models
-
批准号:9111085
-
项目类别:
-
资助金额:$24.79万
-
财政年份:2015
-
负责人:R. PAUL JOHNSON
-
依托单位:
Exome screening and directed breeding of rhesus for human genetic disease models
-
批准号:8970022
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2015
-
负责人:R. PAUL JOHNSON
-
依托单位:
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES
-
批准号:8357947
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION
-
批准号:8357913
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS
-
批准号:8357919
-
项目类别:
-
资助金额:$19.39万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
Immunology
-
批准号:8198155
-
项目类别:
-
资助金额:$36.47万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
Live Attenuated SIV-Mediated Protection Against Mucosal SIV Infection
-
批准号:8198148
-
项目类别:
-
资助金额:$60.16万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION
-
批准号:8357948
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2011
-
负责人:R. PAUL JOHNSON
-
依托单位:
MODULATION OF PD-1 EXPRESSION ON T CELLS IN SIV-INFECTED MACAQUES
-
批准号:8172859
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Construction of a Dual Function Primate Facility: ABSL3 and Transplant Medicine
-
批准号:7877509
-
项目类别:
-
资助金额:$1486.82万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
DELINEATION OF MULTIPLE SUBPOPULATIONS OF NATURAL KILLER CELLS IN MONKEYS
-
批准号:8172823
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8085795
-
项目类别:
-
资助金额:$73.36万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8292099
-
项目类别:
-
资助金额:$75.6万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
IMMUNOLOGICAL REAGENT AND SAMPLE DISTRIBUTION
-
批准号:8172817
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Mechanisms of protective immunity induced by live attenuated SIV vaccines
-
批准号:8064463
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:8467672
-
项目类别:
-
资助金额:$71.07万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
CD8+ T CELLS AND PROTECTION AGAINST VAGINAL CHALLENGE INDUCED BY SIVMAC239DELTA3
-
批准号:8172858
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
Natural killer cells and control of SIV infection
-
批准号:7988488
-
项目类别:
-
资助金额:$79.47万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
SURVIVAL OF THE FITTEST: CHALLENGING TRANSDUCED CELLS WITH HIV-1 REPLICATION
-
批准号:8172860
-
项目类别:
-
资助金额:$20.24万
-
财政年份:2010
-
负责人:R. PAUL JOHNSON
-
依托单位:
海外基金